Alembic Pharmaceuticals Ltd
Sreedhar Konda has extensive experience in pharmaceutical research, currently serving as a Senior Research Scientist at Alembic Pharmaceuticals Limited since January 2017. Prior roles include Scientist at Aurobindo Pharma Ltd. from August 2012 to January 2017, Research Executive at Orchid Pharma from October 2010 to July 2012, Senior Chemist at Inogent Laboratories from May 2009 to October 2010, and Chemist at Suven Life Sciences Ltd. from August 2007 to May 2009. Sreedhar Konda holds a Master of Science degree in Analytical Chemistry from the National Institute of Technology Warangal, earned between 2005 and 2007.
This person is not in any offices
Alembic Pharmaceuticals Ltd
8 followers
Alembic Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged developing formulations and active pharmaceutical ingredients (API). The Company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal, orthopedic, dermatology and ophthalmology. Its APIs include independent manufacturing blocks for Macrolides, non-steroidal anti-inflammatory drugs (NSAIDs) and other drugs. The Company offers international and domestic formulations. Under domestic formulation, it offers Branded Formulations and Generic formulations. Its domestic formulation include Roxid, Zofix, Althrocin, Tellzy AH, Revas H, Lactonic, Folinal, Gestofit, Glisen 1/2, Glimser 1/2, Veldrop, Azithral, Brinzemic and Neolap. Its generic formulations include Cetral, Ephedrex CD, Sicor, Worid, Alcephin, Alcizon, Baciclox, Comeba, Furobid, O Win Suspension, O win T, Silomag Gel, Pentab, Aginal AT and Pyremol.